How Effective Is Proton Beam Therapy For Prostate Cancer?

Fact Checked

SurvivorNet Fact Checking and Medical Review Standards:  

The SurvivorNet News Team creates high quality medical information that complies with our industry leading standards for factual accuracy and sourcing from leading experts at academic medical institutions. Every news article is thoroughly fact-checked by our physician collaborators. We vet each piece of work for factual integrity, impartiality, and clearly label any professional conflicts.

All SurvivorNet articles adhere to the following standards:

  1. All studies and research papers cited are from reputable academic medical institutions or peer-reviewed journals.
  2. When we use data, statistics, or quotes these references link to the original source.
  3. All content related to new treatments, drugs, procedures, and so on must clearly describe availability, side effects, treatment target (such as triple negative breast cancer)
  4. All medical information on SurvivorNet is sourced from respected medical professionals with verified medical credentials and links are provided to these sources.
  5. We strive to give the reader relevant background information and include, clearly-sourced contextual health information in all articles. Readers are clearly alerted to any conflicts of interest from a medical source or the authors of a cited study.
/ Updated August 15th, 2022

How Effective Is Proton Beam Therapy For Prostate Cancer?

NOW
PLAYING
Marketing the Cyberknife for Prostate Cancer: More Dazzle than Data?
NOW
PLAYING
CyberKnife as Effective as Traditional Treatments
NOW
PLAYING
High-Dose Radiation: The Benefit May Outweigh The Risk
NOW
PLAYING
Benefit Of External Beam Radiation: It’s Non-Invasive
NOW
PLAYING
High-Dose Brachytherapy: Temporary and Fast
NOW
PLAYING
What's Involved in Low-Dose Rate Brachytherapy

Patient Pathfinder:

Clinical Trial Finder

Are you looking for other treatment options?
Right now there are ... prostate cancer trials in the U.S. within 100 miles of

Enter your zip code and travel distance to explore trials in your area...

Later Stage Treatment: New Treatment Developments

SEE MORE   

  • There are several new drugs and treatment options available for those facing advanced stage prostate cancer.
  • Two PARP inhibitors are currently FDA-approved: Lynparza (olaparib) and Rubraca (rucaparib).
  • Two newer androgen deprivation therapies include: Xtandi (enzalutamide) Erleada (apalutamide).

Later Stage Treatment: New Treatment Developments

  • There are several new drugs and treatment options available for those facing advanced stage prostate cancer.
  • Two PARP inhibitors are currently FDA-approved: Lynparza (olaparib) and Rubraca (rucaparib).
  • Two newer androgen deprivation therapies include: Xtandi (enzalutamide) Erleada (apalutamide).
×

Get SurvivorNet in Your Inbox

Our newsletter – vital information, hope, and healing, delivered weekly.

Never want to see this again? Click here to dismiss this module permanently.
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.